Management of Sickle Cell Disease in Children

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Southern medical journal (Birmingham, Ala. Print)

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14423/SMJ.0000000000000523PMID 27598348PMCID PMC12858083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

  2016cited by this paper
• CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

  2016cited by this paper
• Intelligence quotient in paediatric sickle cell disease: a systematic review and meta‐analysis

  2016cited by this paper
• Higher-than-expected prevalence of silent cerebral infarcts in children with hemoglobin SC disease.

  2015influential reference
• TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial

  2015cited by this paper
• Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.

  2015cited by this paper
• How I treat and manage strokes in sickle cell disease.

  2015cited by this paper
• Cerebral vasculopathy in children with sickle cell anemia.

  2015cited by this paper
• Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.

  2015cited by this paper
• Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival

  2015cited by this paper
• Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.

  2015cited by this paper
• Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia.

  2015cited by this paper
• Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.

  2015cited by this paper
• Elevated Tricuspid Regurgitant Velocity as a Marker for Pulmonary Hypertension in Children With Sickle Cell Disease: Less Prevalent and Predictive Than Previously Thought?

  2015cited by this paper
• Hydroxycarbamide Decreases Sickle Reticulocyte Adhesion to Resting Endothelium by Inhibiting Endothelial Lutheran/Basal Cell Adhesion Molecule (Lu/BCAM) through Phosphodiesterase 4A Activation*

  2014cited by this paper
• Wheezing symptoms and parental asthma are associated with a physician diagnosis of asthma in children with sickle cell anemia.

  2014cited by this paper
• Parent education and biologic factors influence on cognition in sickle cell anemia

  2014cited by this paper
• Obstructive Sleep Apnea and Sickle Cell Anemia

  2014cited by this paper
• Hydroxyurea and Growth in Young Children With Sickle Cell Disease

  2014cited by this paper
• From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia

  2014cited by this paper
• Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

  2014cited by this paper
• Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

  2014influential reference
• Red blood cell alloimmunization in sickle cell disease: prevalence in 2010

  2013cited by this paper
• Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia

  2013cited by this paper
• Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.

  2013cited by this paper
• Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.

  2013cited by this paper
• Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes

  2013cited by this paper
• A Case of Invasive Streptococcus pneumoniae in an Afebrile Adolescent With Sickle Cell Disease

  2013cited by this paper
• Pneumococcal Bacteremia in a Vaccinated Pediatric Sickle Cell Disease Population

  2012cited by this paper
• Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease.

  2012cited by this paper
• Impact of hydroxyurea on clinical events in the BABY HUG trial.

  2012cited by this paper
• Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

  2012cited by this paper
• Effect of hydroxyurea treatment on renal function parameters: Results from the multi‐center placebo‐controlled BABY HUG clinical trial for infants with sickle cell anemia

  2012cited by this paper
• Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

  2011cited by this paper
• Asthma morbidity and treatment in children with sickle cell disease

  2011cited by this paper
• Chronic kidney disease and albuminuria in children with sickle cell disease.

  2011cited by this paper
• Acute care utilization and rehospitalizations for sickle cell disease.

  2010influential reference
• The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

  2010cited by this paper
• A Critical Reappraisal

  2010cited by this paper
• Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation.

  2010cited by this paper
• Silent infarcts in young children with sickle cell disease

  2009cited by this paper
• Hydroxyurea Generates Nitric Oxide in Human Erythroid Cells: Mechanisms for γ-Globin Gene Activation

  2009cited by this paper
• Lower airway obstruction is associated with increased morbidity in children with sickle cell disease

  2009influential reference
• Improved survival of children and adolescents with sickle cell disease.

  2008influential reference
• Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.

  2008cited by this paper
• Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children

  2008cited by this paper
• Proteinuria in children with sickle cell disease.

  2007cited by this paper
• Asthma is associated with increased mortality in individuals with sickle cell anemia.

  2007cited by this paper
• Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia.

  2006cited by this paper
• Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia.

  2006influential reference
• Primary Hemorrhagic Stroke in Children With Sickle Cell Disease Is Associated With Recent Transfusion and Use of Corticosteroids

  2006cited by this paper
• Hydroxyurea and sickle cell anemia: effect on quality of life

  2006cited by this paper
• Sickle cell hepatopathy: Clinical presentation, treatment, and outcome in pediatric and adult patients

  2005cited by this paper
• Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.

  2005influential reference
• Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients

  2005cited by this paper
• Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

  2004cited by this paper
• Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

  2004influential reference
• Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

  2003cited by this paper
• Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.

  2002cited by this paper
• Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

  2002influential reference
• Multicenter Prospective Study of Children With Sickle Cell Disease: Radiographic and Psychometric Correlation

  2000cited by this paper
• Gallstones in sickle cell disease: observations from The Jamaican Cohort study.

  2000cited by this paper
• Press Review

  2000cited by this paper
• Press Review

  2000cited by this paper
• Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease.

  2000cited by this paper
• Sickle cell pain: a critical reappraisal.

  1998cited by this paper
• Abnormalities of the central nervous system in very young children with sickle cell anemia.

  1998cited by this paper
• Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

  1998cited by this paper
• Cerebrovascular accidents in sickle cell disease: rates and risk factors.

  1998cited by this paper
• Long‐term stroke risk in children with sickle cell disease screened with transcranial doppler

  1997cited by this paper
• Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.

  1996cited by this paper
• Cholelithiasis in children with sickle cell disease

  1996cited by this paper
• Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

  1996cited by this paper
• Cognitive Functioning and Brain Magnetic Resonance Imaging in Children With Sickle Cell Disease

  1996cited by this paper
• Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.

  1995influential reference
• Effects of Total Hemoglobin and Hemoglobin S Concentration on Cerebral Blood Flow During Transfusion Therapy to Prevent Stroke in Sickle Cell Disease

  1994cited by this paper
• Mortality in sickle cell disease. Life expectancy and risk factors for early death.

  1994cited by this paper
• Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.

  1994cited by this paper
• Acute splenic sequestration crisis in sickle cell disease: early detection and treatment.

  1992cited by this paper
• The ocular manifestations of sickle-cell disease: a prevalence and natural history study.

  1992cited by this paper
• Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.

  1992cited by this paper
• Literature abstracts

  1991cited by this paper
• Long-term management of splenic sequestration in children with sickle cell disease.

  1990cited by this paper
• Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

  1986cited by this paper
• Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease.

  1981cited by this paper
• Cholelithiasis in children with sickle cell disease.

  1979cited by this paper
• The prevalence of cholelithiasis in sickle cell disease as diagnosed by ultrasound and cholecystography.

  1979cited by this paper
• Developmental aspects of splenic function in sickle cell diseases.

  1979cited by this paper
• Benign course of extreme hyperbilirubinemia in sickle cell anemia: analysis of six cases.

  1977cited by this paper
• Cholelithiasis in sickle cell anemia.

  1968cited by this paper
• Cholelithiasis in sickle cell anemia.

  1955cited by this paper

• Role of the primary healthcare providers in sickle cell disease management: a scoping review

  2026influential citation
• Problems of parental care for sickle cell children at the ''Gracia Fondation'' treatment center

  2025cites this paper
• Factors the onset of SS anemia and future prospects in the management of sickle cell patients’ management of sickle-cell anemia patients

  2025cites this paper
• Prevalence, Scope and Quality of Extemporaneous Medications in Selected Healthcare Facilities and Implications for Pharmacy Practice

  2024influential citation
• Translation, transcultural adaptation, and validation of PedsQL 3.0 Sickle Cell Disease Module into Brazilian Portuguese

  2024cites this paper
• Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study

  2023cites this paper
• Role of Primary Care in Bridging Gaps in the Health Care System for Vulnerable Children in the United States of America: A Sickle Cell Disease Case Study

  2023cites this paper
• Pediatric sickle cell disease: A case for improved clinician-family partnerships.

  2023cites this paper
• Biopsychosocial Factors Associated with Parenting Stress in Pediatric Sickle Cell Disease

  2022cites this paper
• Transfusion Medicine

  2021cites this paper
• Improvement of SCD morbimortality in children: experience in a remote area of an African country

  2021cites this paper
• Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study

  2021cites this paper
• Hemoglobin disorders in Europe: a systematic effort of identifying and addressing unmet needs and challenges by the Thalassemia International Federation

  2021cites this paper
• Improvement of Sickle Cell Disease Morbimortality in Children: Experience in a Remote Area of an African Country

  2020cites this paper
• Hemoglobinopathies (structural defects in hemoglobin)

  2020cites this paper
• Improvement of Sickle Cell Disease Morbi-Mortality in Children: Experience Gained in a Remote Area of an African Country

  2020cites this paper
• Depression and Anxiety as Moderators of the Pain-Social Functioning Relationship in Youth with Sickle Cell Disease

  2020cites this paper
• Child with unusual combination of sickle cell disease and autosomal recessive agammaglobulinemia associated with a novel CD79a gene mutation

  2019cites this paper
• Important Differences in Hematology Results and Hematological Diseases

  2019cites this paper
• Health Services Access for Young Children with Sickle Cell Anaemia in the Chilubi District of Zambia

  2018cites this paper